Diverse netting approaches create OTC headache

A lack of legal statutes over netting in several Asian countries means OTC trades could become prohibitively expensive in a post-Basel III world, potentially pushing international banks out of some markets in the region


Diversity in Asian capital markets has prompted a slew of issues that are not present for their European or North American peers – the lack of a centre for derivatives trading such as the role London plays in the European Union’s market means there will be a number of clearing houses to emerge. Separate institutions in Seoul, Sydney or Singapore – to name just three examples – will lead to replication of business lines and a fragmentation of collateral.

But the problems don’t stop there and one

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here